BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22305583)

  • 21. Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Murugesan V; Tiwari VS; Saxena R; Tripathi R; Paranjape R; Kulkarni S; Makwana N; Suryawanshi R; Katti SB
    Bioorg Med Chem; 2011 Nov; 19(22):6919-26. PubMed ID: 21982685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and anti-HIV activity of 4'-substituted 4'-thiothymidines: a new entry based on nucleophilic substitution of the 4'-acetoxy group.
    Haraguchi K; Shimada H; Tanaka H; Hamasaki T; Baba M; Gullen EA; Dutschman GE; Cheng YC
    J Med Chem; 2008 Mar; 51(6):1885-93. PubMed ID: 18311897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
    Bodiwala HS; Sabde S; Gupta P; Mukherjee R; Kumar R; Garg P; Bhutani KK; Mitra D; Singh IP
    Bioorg Med Chem; 2011 Feb; 19(3):1256-63. PubMed ID: 21227704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-AIDS agents. Part 61: Anti-HIV activity of new podophyllotoxin derivatives.
    Zhu XK; Guan J; Xiao Z; Cosentino LM; Lee KH
    Bioorg Med Chem; 2004 Aug; 12(15):4267-73. PubMed ID: 15246103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
    Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
    J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly suppressing wild-type HIV-1 and Y181C mutant HIV-1 strains by 10-chloromethyl-11-demethyl-12-oxo-calanolide A with druggable profile.
    Xue H; Lu X; Zheng P; Liu L; Han C; Hu J; Liu Z; Ma T; Li Y; Wang L; Chen Z; Liu G
    J Med Chem; 2010 Feb; 53(3):1397-401. PubMed ID: 20050672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of 6-substituted 5-alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.
    Yu M; Li Z; Liu S; Fan E; Pannecouque C; De Clercq E; Liu X
    ChemMedChem; 2011 May; 6(5):826-33. PubMed ID: 21322110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
    Hegde R; Borkow G; Berchanski A; Lapidot A
    FEBS J; 2007 Dec; 274(24):6523-36. PubMed ID: 18028446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure modifications of 6-aminoquinolones with potent anti-HIV activity.
    Tabarrini O; Stevens M; Cecchetti V; Sabatini S; Dell'Uomo M; Manfroni G; Palumbo M; Pannecouque C; De Clercq E; Fravolini A
    J Med Chem; 2004 Oct; 47(22):5567-78. PubMed ID: 15481992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones.
    Dharmaratne HR; Tan GT; Marasinghe GP; Pezzuto JM
    Planta Med; 2002 Jan; 68(1):86-7. PubMed ID: 11842340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
    King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
    J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication.
    Bridger GJ; Skerlj RT; Hernandez-Abad PE; Bogucki DE; Wang Z; Zhou Y; Nan S; Boehringer EM; Wilson T; Crawford J; Metz M; Hatse S; Princen K; De Clercq E; Schols D
    J Med Chem; 2010 Feb; 53(3):1250-60. PubMed ID: 20043638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of anti-HIV transcription inhibitor quinolones: identification of potent N1-vinyl derivatives.
    Tabarrini O; Massari S; Daelemans D; Meschini F; Manfroni G; Bottega L; Gatto B; Palumbo M; Pannecouque C; Cecchetti V
    ChemMedChem; 2010 Nov; 5(11):1880-92. PubMed ID: 20928882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.
    Liu XY; Yan RZ; Wang Y; Zhan P; De Clercq E; Pannecouque C; Witvrouw M; Molina MT; Vega S
    Arch Pharm (Weinheim); 2008 Apr; 341(4):216-22. PubMed ID: 18266290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives.
    Mai A; Artico M; Sbardella G; Massa S; Novellino E; Greco G; Loi AG; Tramontano E; Marongiu ME; La Colla P
    J Med Chem; 1999 Feb; 42(4):619-27. PubMed ID: 10052969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series.
    Vig R; Mao C; Venkatachalam TK; Tuel-Ahlgren L; Sudbeck EA; Uckun FM
    Bioorg Med Chem Lett; 1998 Jun; 8(12):1461-6. PubMed ID: 9873370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
    Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of 6-arylvinyl analogues of the HIV drugs SJ-3366 and Emivirine.
    Wamberg M; Pedersen EB; El-Brollosy NR; Nielsen C
    Bioorg Med Chem; 2004 Mar; 12(5):1141-9. PubMed ID: 14980626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidones.
    Gardelli C; Nizi E; Muraglia E; Crescenzi B; Ferrara M; Orvieto F; Pace P; Pescatore G; Poma M; Ferreira Mdel R; Scarpelli R; Homnick CF; Ikemoto N; Alfieri A; Verdirame M; Bonelli F; Paz OG; Taliani M; Monteagudo E; Pesci S; Laufer R; Felock P; Stillmock KA; Hazuda D; Rowley M; Summa V
    J Med Chem; 2007 Oct; 50(20):4953-75. PubMed ID: 17824681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents.
    He YP; Long J; Zhang SS; Li C; Lai CC; Zhang CS; Li DX; Zhang DH; Wang H; Cai QQ; Zheng YT
    Bioorg Med Chem Lett; 2011 Jan; 21(2):694-7. PubMed ID: 21194939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.